Sixty seconds on . . . TrialsTracker

BMJ 2016; 355 doi: (Published 08 November 2016) Cite this as: BMJ 2016;355:i5990
  1. Gareth Iacobucci
  1. The BMJ

What’s this? A new app for cycling enthusiasts?

Guess again. It’s actually a new automated tracking service to monitor clinical trials. More specifically, it aims to shine a light on the drug companies and universities that aren’t publishing their trial results.

What’s its verdict?

Pretty damning, overall. The tracker (, developed by academics from Oxford University and some of the key players in the AllTrials campaign (, found that 45% of all trials …

View Full Text

Log in

Log in through your institution


* For online subscription